Unheralded developments in renal cell carcinoma
Not in Chicago – It’s fascinating in a way that while there’s often much time and attention devoted to the big three cancers of breast, lung, and prostate carcinomas, genitourinary cancers such as renal and bladder are often forgotten or sadly ignored.
Not here on BSB – we probably write as often on this segment, as we do about the other categories.
The good news is there are some key abstracts we are looking forward to hearing more about this year with either important top line results to ponder or some detailed biomarker analyses coming out.
As we wait for the digital poster hall to open, it’s time to switch focus from the hurly burly of yesterday’s news…
BSB subscribers can read more on our perspectives regarding renal cell carcinoma, subscribers can log-in or you can click to read our ASCO21 coverage.
This content is restricted to subscribers